Mr Martin Vu
University of Melbourne
16 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Operationalizing the Wilson-Jungner principles for the genomics era: Consensus recommendations from the International Consortium on Newborn Sequencing
DOI: 10.1016/j.gim.2025.1016182025
Journal article
Data-driven consideration of genetic disorders for global genomic newborn screening programs
DOI: 10.1016/j.gim.2025.1014432024
Journal article
Scenario analysis and multi-criteria decision analysis to explore alternative reimbursement pathways for whole genome sequencing for blood cancer patients
DOI: 10.1016/j.jcpo.2024.1005012024
Journal article
Economic Impact of Whole Genome Sequencing and Whole Transcriptome Sequencing Versus Routine Diagnostic Molecular Testing to Stratify Patients with B-Cell Acute Lymphoblastic Leukemia
DOI: 10.1016/j.jmoldx.2024.04.0062024
Journal article
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia
DOI: 10.1007/s40258-023-00826-42023
Thesis / Dissertation
Economic analysis of next-generation sequencing for blood cancers: informing policy decision-making towards reimbursement
2023
Research contracts (non-grants)
Health Economic Analysis of Performing Whole Genome Sequencing of Rare Cancers
RECENT SCHOLARLY WORKS
2023
Journal article
Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review
DOI: 10.1007/s40273-023-01292-52022
Conference Proceedings
COST-EFFECTIVENESS OF TP53 AND IGHV BIOMARKER TESTING PRIOR TO FIRST-LINE TREATMENT WITH NOVEL AGENTS FOR CHRONIC LYMPHOCYTIC LEUKEMIA
DOI: 10.1016/j.jval.2022.09.3932022
Journal article
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review
DOI: 10.1111/ejh.137552021
Conference Proceedings
Diagnostic Utility of Multimodal Genomic Profiling for Molecular Classification and MRD Assessment in Adult B-Cell Acute Lymphoblastic Leukemia
DOI: 10.1182/blood-2021-146396